• Clinical Trials - Pneumonia

    Study Objective Contact
    A Randomized Double-Blind, Placebo-Controlled, Parallel Group, Phase 2 Study of Aerosolized Amikacin and Fosfomycin Delivered via the Investigational eFlow® Inline System in Mechanically Ventilated Patients with Gram-Negative Bacterial Pneumonia (IASIS) [LCID Study Number: 2014-031] The purpose of this study is to test the effectiveness, safety and side effects of an investigational new drug delivery system, Amikacin Fosfomycin Inhalation System (AFIS), for patients with a specific type of bacterial pneumonia. Patients will be enrolled into the study by invitation only. Principal Investigator(s):
    Donald Craven, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Yuxiu Lei, PhD.